Data / Drug companies / Sportpharm LLC
Sportpharm LLC: 292 products in the FDA NDC directory, labeler code 85766
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sportpharm LLC (labeler code 85766) lists 292 products in the FDA National Drug Code Directory, covering 138 finished drugs by generic name. By type: 236 prescription drugs, 55 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 1, 2026.
The request: Watch Sportpharm LLC (FDA labeler code 85766): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85766
- Products in commercial distribution
- 292
- Packages
- 1,014
- Finished drugs by generic name
- 138
- Prescription products
- 236
- Over the counter products
- 55
- Started marketing in the last 12 months
- 19
- Products with a marketing end date set
- 2
- Earliest marketing start
- April 2, 1959
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 223 | 76.4% |
| Over the counter monograph drugs | 26 | 8.9% |
| New drug applications (NDA) | 24 | 8.2% |
| Authorized generics (NDA) | 15 | 5.1% |
| Biologics (BLA) | 2 | 0.7% |
| Other unapproved drugs | 2 | 0.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 236 | 80.8% |
| Over the counter drugs | 55 | 18.8% |
| Vaccines | 1 | 0.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 61 | 20.9% |
| Tablet, film coated | 50 | 17.1% |
| Injection, solution | 29 | 9.9% |
| Capsule | 25 | 8.6% |
| Injection | 13 | 4.5% |
| Cream | 11 | 3.8% |
| Solution | 11 | 3.8% |
| Solution/ drops | 10 | 3.4% |
| Injection, suspension | 9 | 3.1% |
| Suspension/ drops | 7 | 2.4% |
| Spray | 6 | 2.1% |
| Injection, powder, for solution | 6 | 2.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Flucelvax | 85766-263 | Injection, suspension | Biologics (BLA) | July 1, 2026 |
| Sudafed PE Sinus Pressure Plus Pain | 85766-183 | Tablet, film coated | Over the counter monograph drugs | March 10, 2026 |
| Medi-First Plus Sinus Decongestant | 85766-182 | Tablet, film coated | Over the counter monograph drugs | March 7, 2026 |
| Foster and thrive daytime severe cold and flu relief | 85766-179 | Tablet, film coated | Over the counter monograph drugs | March 7, 2026 |
| Nasal Decongestant PE Maximum Strength | 85766-178 | Tablet, film coated | Over the counter monograph drugs | March 7, 2026 |
| Foster and thrive nighttime cold and flu relief | 85766-177 | Solution | Over the counter monograph drugs | March 4, 2026 |
| Medique Medi-Meclizine | 85766-175 | Tablet | Over the counter monograph drugs | February 27, 2026 |
| Medique at Home Decorel Forte | 85766-174 | Tablet, film coated | Over the counter monograph drugs | February 27, 2026 |
| Medique Pain Off | 85766-173 | Tablet, film coated | Over the counter monograph drugs | February 27, 2026 |
| Hydrocortisone | 85766-166 | Cream | Over the counter monograph drugs | February 24, 2026 |
| GoodSense Eye Drops Advanced Relief Moisturizer | 85766-165 | Solution | Over the counter monograph drugs | February 7, 2026 |
| Good Sense Nasal | 85766-164 | Spray | Over the counter monograph drugs | February 7, 2026 |
| Loperamide Hydrochloride | 85766-154 | Tablet | Generic drugs (ANDA) | February 6, 2026 |
| Pain Relief Gel-Patch | 85766-153 | Patch | Over the counter monograph drugs | February 6, 2026 |
| Hydrocortisone | 85766-151 | Cream | Over the counter monograph drugs | February 6, 2026 |
| Stimulant laxative enteric coated | 85766-148 | Tablet | Over the counter monograph drugs | February 6, 2026 |
| Adult Low Dose Enteric Coated Aspirin | 85766-147 | Tablet, coated | Over the counter monograph drugs | February 6, 2026 |
| Besivance | 85766-260 | Suspension | New drug applications (NDA) | January 9, 2026 |
| Medique at Home Aspirin | 85766-125 | Tablet, film coated | Over the counter monograph drugs | December 2, 2025 |
| Glucagon | 85766-043 | Kit | Generic drugs (ANDA) | October 8, 2025 |
| Ipratropium bromide | 85766-242 | Spray, metered | Generic drugs (ANDA) | July 3, 2025 |
| Allopurinol | 85766-288 | Tablet | Generic drugs (ANDA) | April 14, 2025 |
| Allopurinol | 85766-287 | Tablet | Generic drugs (ANDA) | April 14, 2025 |
| Neffy | 85766-129 | Spray | New drug applications (NDA) | March 5, 2025 |
| Glucagon | 85766-065 | Kit | Generic drugs (ANDA) | February 26, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.